Table of Contents 1 Market Overview 1.1 Gastrointestinal Cancer Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Oncology 1.2.2 Radiology 1.2.3 Others 1.3 Market Analysis by Applications 1.3.1 Hospitals 1.3.2 Specialized Cancer Treatment Centers 1.3.3 Clinics 1.3.4 Ambulatory Surgical Centers 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Amgen Limited & Amgen Ireland Limited 2.1.1 Business Overview 2.1.2 Gastrointestinal Cancer Drugs Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Bristol-Myers Squibb Company 2.2.1 Business Overview 2.2.2 Gastrointestinal Cancer Drugs Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 F. Hoffmann-La Roche Ltd. 2.3.1 Business Overview 2.3.2 Gastrointestinal Cancer Drugs Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Eli Lilly and Company 2.4.1 Business Overview 2.4.2 Gastrointestinal Cancer Drugs Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Johnson & Johnson Private Limited 2.5.1 Business Overview 2.5.2 Gastrointestinal Cancer Drugs Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 GlaxoSmithKline plc. 2.6.1 Business Overview 2.6.2 Gastrointestinal Cancer Drugs Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 GlaxoSmithKline plc. Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Celgene Corporation 2.7.1 Business Overview 2.7.2 Gastrointestinal Cancer Drugs Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Pfizer Inc. 2.8.1 Business Overview 2.8.2 Gastrointestinal Cancer Drugs Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Pfizer Inc. Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Sanofi 2.9.1 Business Overview 2.9.2 Gastrointestinal Cancer Drugs Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Sanofi Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Novartis AG 2.10.1 Business Overview 2.10.2 Gastrointestinal Cancer Drugs Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Novartis AG Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Gastrointestinal Cancer Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 Gastrointestinal Cancer Drugs Manufacturer Market Share in 2017 3.3.2 Top 6 Gastrointestinal Cancer Drugs Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global Gastrointestinal Cancer Drugs Market Analysis by Regions 4.1 Global Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Regions 4.1.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Regions (2013-2018) 4.1.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Regions (2013-2018) 4.2 North America Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 4.3 Europe Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 4.5 South America Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 5 North America Gastrointestinal Cancer Drugs by Countries 5.1 North America Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries 5.1.1 North America Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018) 5.1.2 North America Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018) 5.2 United States Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 5.3 Canada Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 5.4 Mexico Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 6 Europe Gastrointestinal Cancer Drugs by Countries 6.1 Europe Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries 6.1.1 Europe Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018) 6.1.2 Europe Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018) 6.2 Germany Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 6.3 UK Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 6.4 France Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 6.5 Russia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 6.6 Italy Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 7 Asia-Pacific Gastrointestinal Cancer Drugs by Countries 7.1 Asia-Pacific Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018) 7.2 China Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 7.3 Japan Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 7.4 Korea Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 7.5 India Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 7.6 Southeast Asia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 8 South America Gastrointestinal Cancer Drugs by Countries 8.1 South America Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries 8.1.1 South America Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018) 8.1.2 South America Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018) 8.2 Brazil Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 8.3 Argentina Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 8.4 Colombia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 9 Middle East and Africa Gastrointestinal Cancer Drugs by Countries 9.1 Middle East and Africa Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 9.3 UAE Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 9.4 Egypt Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 9.5 Nigeria Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 9.6 South Africa Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) 10 Global Gastrointestinal Cancer Drugs Market Segment by Type 10.1 Global Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Type (2013-2018) 10.1.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Type (2013-2018) 10.2 Oncology Sales Growth and Price 10.2.1 Global Oncology Sales Growth (2013-2018) 10.2.2 Global Oncology Price (2013-2018) 10.3 Radiology Sales Growth and Price 10.3.1 Global Radiology Sales Growth (2013-2018) 10.3.2 Global Radiology Price (2013-2018) 10.4 Others Sales Growth and Price 10.4.1 Global Others Sales Growth (2013-2018) 10.4.2 Global Others Price (2013-2018) 11 Global Gastrointestinal Cancer Drugs Market Segment by Application 11.1 Global Gastrointestinal Cancer Drugs Sales Market Share by Application (2013-2018) 11.2 Hospitals Sales Growth (2013-2018) 11.3 Specialized Cancer Treatment Centers Sales Growth (2013-2018) 11.4 Clinics Sales Growth (2013-2018) 11.5 Ambulatory Surgical Centers Sales Growth (2013-2018) 12 Gastrointestinal Cancer Drugs Market Forecast (2018-2023) 12.1 Global Gastrointestinal Cancer Drugs Sales, Revenue and Growth Rate (2018-2023) 12.2 Gastrointestinal Cancer Drugs Market Forecast by Regions (2018-2023) 12.2.1 North America Gastrointestinal Cancer Drugs Market Forecast (2018-2023) 12.2.2 Europe Gastrointestinal Cancer Drugs Market Forecast (2018-2023) 12.2.3 Asia-Pacific Gastrointestinal Cancer Drugs Market Forecast (2018-2023) 12.2.4 South America Gastrointestinal Cancer Drugs Market Forecast (2018-2023) 12.2.5 Middle East and Africa Gastrointestinal Cancer Drugs Market Forecast (2018-2023) 12.3 Gastrointestinal Cancer Drugs Market Forecast by Type (2018-2023) 12.3.1 Global Gastrointestinal Cancer Drugs Sales Forecast by Type (2018-2023) 12.3.2 Global Gastrointestinal Cancer Drugs Market Share Forecast by Type (2018-2023) 12.4 Gastrointestinal Cancer Drugs Market Forecast by Application (2018-2023) 12.4.1 Global Gastrointestinal Cancer Drugs Sales Forecast by Application (2018-2023) 12.4.2 Global Gastrointestinal Cancer Drugs Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Gastrointestinal Cancer Drugs Picture Table Product Specifications of Gastrointestinal Cancer Drugs Figure Global Sales Market Share of Gastrointestinal Cancer Drugs by Types in 2017 Table Gastrointestinal Cancer Drugs Types for Major Manufacturers Figure Oncology Picture Figure Radiology Picture Figure Others Picture Figure Gastrointestinal Cancer Drugs Sales Market Share by Applications in 2017 Figure Hospitals Picture Figure Specialized Cancer Treatment Centers Picture Figure Clinics Picture Figure Ambulatory Surgical Centers Picture Figure United States Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Canada Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Germany Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure France Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure UK Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Russia Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Italy Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure China Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Japan Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Korea Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure India Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Gastrointestinal Cancer Drugs Revenue (Value) and Growth Rate (2013-2023) Table Amgen Limited & Amgen Ireland Limited Basic Information, Manufacturing Base and Competitors Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Type and Applications Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Type and Applications Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors Table F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drugs Type and Applications Table F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors Table Eli Lilly and Company Gastrointestinal Cancer Drugs Type and Applications Table Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Johnson & Johnson Private Limited Basic Information, Manufacturing Base and Competitors Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Type and Applications Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline plc. Gastrointestinal Cancer Drugs Type and Applications Table GlaxoSmithKline plc. Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Celgene Corporation Basic Information, Manufacturing Base and Competitors Table Celgene Corporation Gastrointestinal Cancer Drugs Type and Applications Table Celgene Corporation Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors Table Pfizer Inc. Gastrointestinal Cancer Drugs Type and Applications Table Pfizer Inc. Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Gastrointestinal Cancer Drugs Type and Applications Table Sanofi Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novartis AG Basic Information, Manufacturing Base and Competitors Table Novartis AG Gastrointestinal Cancer Drugs Type and Applications Table Novartis AG Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Gastrointestinal Cancer Drugs Sales by Manufacturer (2016-2017) Figure Global Gastrointestinal Cancer Drugs Sales Market Share by Manufacturer in 2016 Figure Global Gastrointestinal Cancer Drugs Sales Market Share by Manufacturer in 2017 Table Global Gastrointestinal Cancer Drugs Revenue by Manufacturer (2016-2017) Figure Global Gastrointestinal Cancer Drugs Revenue Market Share by Manufacturer in 2016 Figure Global Gastrointestinal Cancer Drugs Revenue Market Share by Manufacturer in 2017 Figure Top 3 Gastrointestinal Cancer Drugs Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Gastrointestinal Cancer Drugs Manufacturer (Revenue) Market Share in 2017 Figure Global Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Global Gastrointestinal Cancer Drugs Revenue and Growth Rate (2013-2018) Table Global Gastrointestinal Cancer Drugs Sales by Regions (2013-2018) Table Global Gastrointestinal Cancer Drugs Sales Market Share by Regions (2013-2018) Table Global Gastrointestinal Cancer Drugs Revenue by Regions (2013-2018) Figure Global Gastrointestinal Cancer Drugs Revenue Market Share by Regions in 2013 Figure Global Gastrointestinal Cancer Drugs Revenue Market Share by Regions in 2017 Figure North America Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Europe Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Asia-Pacific Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure South America Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Middle East and Africa Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure North America Gastrointestinal Cancer Drugs Revenue and Growth Rate (2013-2018) Table North America Gastrointestinal Cancer Drugs Sales by Countries (2013-2018) Table North America Gastrointestinal Cancer Drugs Sales Market Share by Countries (2013-2018) Figure North America Gastrointestinal Cancer Drugs Sales Market Share by Countries in 2013 Figure North America Gastrointestinal Cancer Drugs Sales Market Share by Countries in 2017 Table North America Gastrointestinal Cancer Drugs Revenue by Countries (2013-2018) Table North America Gastrointestinal Cancer Drugs Revenue Market Share by Countries (2013-2018) Figure North America Gastrointestinal Cancer Drugs Revenue Market Share by Countries in 2013 Figure North America Gastrointestinal Cancer Drugs Revenue Market Share by Countries in 2017 Figure United States Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Canada Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Mexico Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Europe Gastrointestinal Cancer Drugs Revenue and Growth Rate (2013-2018) Table Europe Gastrointestinal Cancer Drugs Sales by Countries (2013-2018) Table Europe Gastrointestinal Cancer Drugs Sales Market Share by Countries (2013-2018) Table Europe Gastrointestinal Cancer Drugs Revenue by Countries (2013-2018) Figure Europe Gastrointestinal Cancer Drugs Revenue Market Share by Countries in 2016 Figure Europe Gastrointestinal Cancer Drugs Revenue Market Share by Countries in 2017 Figure Germany Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure UK Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure France Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Russia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Italy Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Asia-Pacific Gastrointestinal Cancer Drugs Revenue and Growth Rate (2013-2018) Table Asia-Pacific Gastrointestinal Cancer Drugs Sales by Countries (2013-2018) Table Asia-Pacific Gastrointestinal Cancer Drugs Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Gastrointestinal Cancer Drugs Sales Market Share by Countries 2017 Table Asia-Pacific Gastrointestinal Cancer Drugs Revenue by Countries (2013-2018) Figure Asia-Pacific Gastrointestinal Cancer Drugs Revenue Market Share by Countries 2017 Figure China Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Japan Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Korea Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure India Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Southeast Asia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure South America Gastrointestinal Cancer Drugs Revenue and Growth Rate (2013-2018) Table South America Gastrointestinal Cancer Drugs Sales by Countries (2013-2018) Table South America Gastrointestinal Cancer Drugs Sales Market Share by Countries (2013-2018) Figure South America Gastrointestinal Cancer Drugs Sales Market Share by Countries in 2017 Table South America Gastrointestinal Cancer Drugs Revenue by Countries (2013-2018) Table South America Gastrointestinal Cancer Drugs Revenue Market Share by Countries (2013-2018) Figure South America Gastrointestinal Cancer Drugs Revenue Market Share by Countries in 2017 Figure Brazil Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Argentina Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Colombia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Middle East and Africa Gastrointestinal Cancer Drugs Revenue and Growth Rate (2013-2018) Table Middle East and Africa Gastrointestinal Cancer Drugs Sales by Countries (2013-2018) Table Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share by Countries in 2017 Table Middle East and Africa Gastrointestinal Cancer Drugs Revenue by Countries (2013-2018) Table Middle East and Africa Gastrointestinal Cancer Drugs Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Gastrointestinal Cancer Drugs Revenue Market Share by Countries in 2013 Figure Middle East and Africa Gastrointestinal Cancer Drugs Revenue Market Share by Countries in 2017 Figure Saudi Arabia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure UAE Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Egypt Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure Nigeria Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Figure South Africa Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018) Table Global Gastrointestinal Cancer Drugs Sales by Type (2013-2018) Table Global Gastrointestinal Cancer Drugs Sales Share by Type (2013-2018) Table Global Gastrointestinal Cancer Drugs Revenue by Type (2013-2018) Table Global Gastrointestinal Cancer Drugs Revenue Share by Type (2013-2018) Figure Global Oncology Sales Growth (2013-2018) Figure Global Oncology Price (2013-2018) Figure Global Radiology Sales Growth (2013-2018) Figure Global Radiology Price (2013-2018) Figure Global Others Sales Growth (2013-2018) Figure Global Others Price (2013-2018) Table Global Gastrointestinal Cancer Drugs Sales by Application (2013-2018) Table Global Gastrointestinal Cancer Drugs Sales Share by Application (2013-2018) Figure Global Specialized Cancer Treatment Centers Sales Growth (2013-2018) Figure Global Clinics Sales Growth (2013-2018) Figure Global Ambulatory Surgical Centers Sales Growth (2013-2018) Figure Global Gastrointestinal Cancer Drugs Sales, Revenue and Growth Rate (2018-2023) Table Global Gastrointestinal Cancer Drugs Sales Forecast by Regions (2018-2023) Table Global Gastrointestinal Cancer Drugs Market Share Forecast by Regions (2018-2023) Figure North America Sales Gastrointestinal Cancer Drugs Market Forecast (2018-2023) Figure Europe Sales Gastrointestinal Cancer Drugs Market Forecast (2018-2023) Figure Asia-Pacific Sales Gastrointestinal Cancer Drugs Market Forecast (2018-2023) Figure South America Sales Gastrointestinal Cancer Drugs Market Forecast (2018-2023) Figure Middle East and Africa Sales Gastrointestinal Cancer Drugs Market Forecast (2018-2023) Table Global Gastrointestinal Cancer Drugs Sales Forecast by Type (2018-2023) Table Global Gastrointestinal Cancer Drugs Market Share Forecast by Type (2018-2023) Table Global Gastrointestinal Cancer Drugs Sales Forecast by Application (2018-2023) Table Global Gastrointestinal Cancer Drugs Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Amgen Limited & Amgen Ireland Limited Bristol-Myers Squibb Company F. Hoffmann-La Roche Ltd. Eli Lilly and Company Johnson & Johnson Private Limited GlaxoSmithKline plc. Celgene Corporation Pfizer Inc. Sanofi Novartis AG